SWOG clinical trial number
S0713
A Phase II Study of Oxaliplatin, Capecitabine, Cetuximab and Radiation in Pre-operative Therapy of Rectal Cancer
94% Accrual
Accrual
94%
Closed
Phase
94% Accrual
Accrual
94%
Published
Abbreviated Title
Ph II Rectal Pre-Operative ChemoRT
Activated
02/01/2009
Closed
04/15/2013
Participants
Research committees
Gastrointestinal Cancer
Treatment
Oxaliplatin
Capecitabine
Cetuximab
Eligibility Criteria Expand/Collapse
Publication Information Expand/Collapse
Other Clinical Trials
S2303
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
05/06/2024
Open
CTSU/A022101
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
Phase
S2107
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
100% Accrual
Accrual
100%
Open
Phase